File(s) not publicly available
PHASE II TRIAL OF CONTINUOUS LOW-DOSE TEMOZOLOMIDE (TMZ) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA (MG) WITH AND WITHOUT PRIOR EXPOSURE TO BEVACIZUMAB (REV)
conference contribution
posted on 2010-11-01, 00:00 authored by Mustafa Khasraw, Lauren E Abrey, Andrew B Lassman, Adilia Hormigo, Craig Nolan, Igor T Gavrilovic, Ingo K Mellinghoff, Anne S Reiner, Lisa DeAngelis, Antonio M OmuroPHASE II TRIAL OF CONTINUOUS LOW-DOSE TEMOZOLOMIDE (TMZ) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA (MG) WITH AND WITHOUT PRIOR EXPOSURE TO BEVACIZUMAB (REV)
